Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells

Cancer Genomics and Proteomics

Volumn 9, Issue 5, 2012, Pages 321-328

  Ji, Ke ^a   Ye, Lin ^a   Toms, Anne Marie ^a   Hargest, Rachel ^a   Martin, Tracey A ^a   Ruge, Fiona ^a   Ji, Jiafu ^a,b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PEKING UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Growth; Migration and invasion; Signal induced proliferation associated gene 1; SIPA1

Indexed keywords

RIBOZYME;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; REAL TIME POLYMERASE CHAIN REACTION; SIPA1 GENE; TRANSGENE;

EID: 84867394802     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dukes CE and Bussey HJ: The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309-320, 1958
2. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E and Colquhoun K: A multivariate analysis of clinical and pathological variables in prognosis after rescetion of large bowel cancer. Br J Cancer 72: 1424-1429, 1985
3. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse J and Welch DR: Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 61: 8866-8872, 2001. (Pubitemid 34013902)
4. Gaudet MM, Hunter K, Pharoah P and Dunning AM: Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer 124(7): 1716-1720, 2009.
5. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A, Eckert A and Puri V: SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-D621, 2006.
6. Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H and Hunter KW: Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 8: R16, 2006.
7. Page DL: Prognosis and breast cancer.Recognition of lethal and favorable prognostic types. Am J SurgPathol 15: 334-349, 1991.
8. Platet N, Cathiard AM, Gleizes M and Garcia M: Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51: 55-67, 2004. (Pubitemid 38781751)
9. Shimizu Y, Hamazaki Y, Hattori M, Doi K, Terada N, Kobayashi T, Toda Y, Yamasaki T, Inoue T, Kajita Y, Maeno A, Kamba T, Mikami Y, Kamoto T, Yamada T, Kanno T, Yoshikawa K, Ogawa O, Minato N and Nakamura E: SPA-1 controls the invasion and metastasis of human prostate cancer. Cancer Sci 102: 828-836, 2011.
10. Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE and Rader JS: Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. Gynecol Oncol 116: 539-543, 2010.
11. Minato N and Hattori M: Spa-1 (Sipa1) and RAP signaling in leukemia and cancer metastasis. Cancer Sci 100: 17-23, 2009.
12. Bailey CL, Kelly P and Casey PJ: Activation of RAP1 promotes prostate cancer metastasis. Cancer Res 69: 4962-4968, 2009.
13. Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H and Hunter KW: Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 8: R16, 2006.
14. Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415, 2003.
15. Jiang WG, Grimshaw D, Lane J, Martin TA, Abounader R, Laterra J and Mansel RE: A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin Cancer Res 7: 2555-2562, 2001. (Pubitemid 32751662)
16. Ye L, Bokobza S, Li J, Moazzam M, Chen J, Mansel RE and Jiang WG: Bone morphogenetic protein-10 (BMP-10) inhibit saggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer, Cancer Science 101: 2137-2144, 2010.
17. Ishida D, Kometani K, Yang H, Kakugawa K, Masuda K, Iwai K, Suzuki M, Itohara S, Nakahata T, Hiai H, Kawamoto H, Hattori M and Minato N: Myeloproliferative stem cell disorders by deregulated Rap1 activation in Spa-1-deficient mice. Cancer Cell 4: 55-65, 2003. (Pubitemid 36904161)
18. Ishida D, Yang H, Masuda K, Uesugi K, Kawamoto H, Hattori M and Minato N: Antigen-driven T cell anergy and defective memory T-cell response via deregulated RAP1 activation in Spa-1-deficient mice. Proc Natl Acad Sci USA 100: 10919-10924, 2003. (Pubitemid 37140128)
19. Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M and Minato N: Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model. Cancer Res 66: 9967-9976, 2006. (Pubitemid 44672049)
20. Fralix KD, Zhao S, Venkatasubbarao K and Freeman JW: RAP1 reverses transcriptional repression of TGF-β type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. J Cell Physiol 194: 88-99, 2003. (Pubitemid 35424231)